Results 161 to 170 of about 17,534 (188)
Some of the next articles are maybe not open access.
CURRENT CONCEPTS IN THE MANAGEMENT OF INTRACRANIAL ATHEROSCLEROTIC DISEASE
Neurosurgery, 2006Abstract MEDICALLY REFRACTORY, SYMPTOMATIC intracranial atherosclerotic disease has a poor prognosis. Based on the results of the Warfarin-Aspirin Symptomatic Intracranial Disease study, the risk of ipsilateral stroke at 1.8 years is between 13 and 14% in patients with symptomatic intracranial atherosclerosis.
Robert D, Ecker +4 more
openaire +3 more sources
Non-Atherosclerotic Intracranial Arterial Diseases
2016Atherosclerosis is not the only cause of intracranial arterial disease. Arterial dissection, moyamoya disease, vascular inflammatory disease, vasospasm and immunologic disorders are important non-atherosclerotic intracranial arterial diseases. Identification of the correct etiology is important in establishing treatment strategies and assessing ...
Jong S, Kim, Louis R, Caplan
openaire +2 more sources
Intraplaque Hemorrhage in Symptomatic Intracranial Atherosclerotic Disease
Journal of Neuroimaging, 2011Studies in patients with extracranial carotid disease have shown that high-resolution magnetic resonance direct thrombus imaging (MRDTI) can reliably identify intraplaque hemorrhage, which may be a better predictor of clinical events than traditional radiographic methods such as percent stenosis. We present the use of high-resolution magnetic resonance
Tanya N, Turan +4 more
openaire +2 more sources
Hemodynamics and stroke risk in intracranial atherosclerotic disease
Annals of Neurology, 2019ObjectiveTo investigate whether hemodynamic features of symptomatic intracranial atherosclerotic stenosis (sICAS) might correlate with the risk of stroke relapse, using a computational fluid dynamics (CFD) model.MethodsIn a cohort study, we recruited patients with acute ischemic stroke attributed to 50 to 99% ICAS confirmed by computed tomographic ...
Xinyi Leng +20 more
openaire +2 more sources
Medical Treatment of Patients with Intracranial Atherosclerotic Disease
Journal of Neuroimaging, 2009ABSTRACT The medical treatment of patients with symptomatic intracranial atherosclerotic disease (ICAD) is directed toward reducing the risk of new ischemic events. The overall strategy is divided into: (1) prevention of occurrence of intraluminal thrombus, with or without embolism; (2) plaque stabilization and regression; and (3) management of ...
Camilo R, Gomez, Adnan I, Qureshi
openaire +2 more sources
Epidemiology, diagnosis and management of intracranial atherosclerotic disease
Expert Review of Cardiovascular Therapy, 2010Intracranial atherosclerotic disease (ICAD) is a major cause of ischemic stroke, with higher occurrence rates in Asian, black and Hispanic individuals than in white individuals. Important risk factors for ICAD include age, hypertension, diabetes mellitus and metabolic syndrome. ICAD patients have a 10–20% annual risk of stroke, with greater risk
Jiann-Shing, Jeng +2 more
openaire +2 more sources
Intracranial stenting for intracranial atherosclerotic disease: still much to learn
Journal of NeuroInterventional Surgery, 2012The recently published Stenting versus Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) study1 has provided seminal information on the treatment of symptomatic intracranial atherosclerotic disease (ICAD). However, with some perceived study design flaws and patient group exclusions, this study is only one
openaire +2 more sources
Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease
StrokeIntracranial atherosclerotic disease (ICAD) is one of the most common causes of stroke worldwide. Among people with stroke, those of East Asia descent and non-White populations in the United States have a higher burden of ICAD-related stroke compared with Whites of European descent.
Li Hui Chen +4 more
openaire +2 more sources